切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2018, Vol. 13 ›› Issue (06) : 439 -443. doi: 10.3877/cma.j.issn.1673-9450.2018.06.008

所属专题: 文献

论著

异体富血小板血浆免疫原性的小型猪动物实验研究
姚丹1, 赵帆2, 郝岱峰2,(), 冯光2, 褚万立2, 陈泽群2   
  1. 1. 100853 北京,解放军总医院;100048 北京,解放军总医院第四医学中心烧伤整形暨创面修复中心
    2. 100048 北京,解放军总医院第四医学中心烧伤整形暨创面修复中心
  • 收稿日期:2018-10-12 出版日期:2018-12-01
  • 通信作者: 郝岱峰
  • 基金资助:
    国家自然科学基金青年项目(81601730); 全军后勤科研计划重点项目(BWS14J049); 北京市自然科学基金面上项目(7182160)

Animal experimental study on the immunogenicity of allogeneic platelet-rich plasma in mini-pigs

Dan Yao1, Fan Zhao2, Daifeng Hao2,(), Guang Feng2, Wanli Chu2, Zequn Chen2   

  1. 1. People′s Liberation Army General Hospital, Beijing 100853, China; Department of Burns and Plastic Surgery, Wound Repair Center, Fourth Medical Center of People′s Liberation Army General Hospital, Beijing 100048, China
    2. Department of Burns and Plastic Surgery, Wound Repair Center, Fourth Medical Center of People′s Liberation Army General Hospital, Beijing 100048, China
  • Received:2018-10-12 Published:2018-12-01
  • Corresponding author: Daifeng Hao
  • About author:
    Corresponding author: Hao Daifeng, Email:
引用本文:

姚丹, 赵帆, 郝岱峰, 冯光, 褚万立, 陈泽群. 异体富血小板血浆免疫原性的小型猪动物实验研究[J]. 中华损伤与修复杂志(电子版), 2018, 13(06): 439-443.

Dan Yao, Fan Zhao, Daifeng Hao, Guang Feng, Wanli Chu, Zequn Chen. Animal experimental study on the immunogenicity of allogeneic platelet-rich plasma in mini-pigs[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2018, 13(06): 439-443.

目的

评价异体富血小板血浆(PRP)在小型猪体内产生的免疫原性反应。

方法

无菌条件下经颈动脉取1只雄性巴马小型猪全血,第1次以1 000×g力离心15 min分离红细胞,第2次以3 000×g力离心10 min获取PRP;剩余9只雄性巴马小型猪,抽签法选取3只,取其耳缘静脉血各1.0 mL。后9只小型猪双侧股部分别注射激活的异体PRP 0.5 mL,按抽签法分为1、2、4周组,每组3只,于异体PRP注射后1、2、4周分别取对应组各小型猪耳缘静脉血1.0 mL,之后处死该小型猪,取注射部位组织。流式细胞仪检测比较CD4/CD8T淋巴细胞亚群比例,生物显微镜下观察组织形态学变化及免疫组织化学分析局部组织免疫原性反应。对数据行单因素方差分析和Dunnett-t检验。

结果

小型猪肌肉注射异体PRP前,CD4/CD8T淋巴细胞亚群比例为0.75±0.04,异体PRP注射后1、2、4周CD4/CD8T淋巴细胞亚群比例分别为0.96±0.02、0.85±0.02、0.79±0.02,比较差异有统计学意义(F=37.970,P<0.001)。异体PRP注射后1、2周CD4/CD8T淋巴细胞亚群比例与参照组比较,差异均有统计学意义(P<0.001、=0.004);异体PRP注射后4周CD4/CD8T淋巴细胞亚群比例与参照组比较,差异无统计学意义(P=0.201)。病理检查可见,异体PRP注射部位的局部组织于注射后1周有轻微炎性细胞浸润和白细胞介素-2(IL-2)的表达,注射后2、4周炎性细胞浸润逐渐消失,IL-2表达转为阴性。

结论

异体PRP注射仅在小型猪体内产生轻微的局部和全身免疫原性反应,且在注射后4周该免疫原性反应基本消失。

Objective

To estimate the immunogenicity of allogeneic platelet-rich plasma(PRP) in mini-pigs.

Methods

Blood was drawn from the carotid artery of one Bama mini-pig under the sterile condition, and then centrifuged twice, first at 1 000×g for 15 min to remove red blood cells, and then at 3 000×g for 10 min to obtain PRP. One milliliter of blood was respectively drawn from the ear vein of 3 mini-pigs which were drawn from the remaining 9 mini-pigs. Allogeneic PRP gel was injected into 9 male mini-pigs′ gluteus maximus muscles bilaterally(0.5 mL of PRP in each injection site). Divided the mini-pigs into 1 week group, 2 weeks group and 4 weeks group by sortition randomization method, 3 pigs in each group. One milliliter of blood was respectively drawn from the ear vein of corresponding group 1, 2, 4 weeks after the injection, and then mini-pigs were sacrificed and the muscle samples from injection site was obtained at each time point. The change of CD4+ and CD8+ T lymphocyte subpopulation were detected and compared through flow cytometry. Histomorphological changes and immunohistochemical analysis of local tissue immunogenic responses were observed under biological microscope. Data were processed with one-way analysis of variance and Dunnett-t test.

Results

Before the intramuscular injection of allogeneic PRP, the ratio of CD4+ and CD8+ T lymphocyte subpopulation in peripheral blood was 0.75±0.04, which respectively changed to 0.96±0.02, 0.85±0.02 and 0.79±0.02 at week 1, week 2 and week 4 after injection. The difference was statistically significant (F=37.970, P<0.001). Compared with the CD4+ /CD8+ cell ratio before the injection, there were significant differences at 1 week group and 2 weeks group respectively(P<0.001, =0.004). There were no obvious difference in CD4+ /CD8+ cell ratio bettween 4 weeks group and normal physical level. Histopathologic examination revealed that the intramuscular injection of allogeneic PRP only caused subtle inflammation and little expression of IL-2 around the injection site at week 1, which decreased at week 2 and did not persist till week 4.

Conclusions

Allogeneic platelet-rich plasma can cause minor local and systemic immune response in mini-pigs. The responses will get weaker and disappeared after 4 weeks.

图1 生物显微镜下观察小型猪异体PRP肌肉注射后不同时相点注射部位组织变化(苏木精-伊红染色,×200)。A示注射后1周,局部注射部位肌肉组织中有部分炎性细胞浸润,肌细胞结构完整,排列整齐,未见组织变性坏死;B示注射后2周,可见局部注射部位肌肉组织中炎性细胞浸润明显减少,炎症反应明显减轻;C示注射后4周,注射部位肌肉组织中炎性细胞浸润消失,与周围正常肌细胞无异;PRP为富血小板血浆
图2 小型猪异体PRP肌肉注射后不同时相点注射部位免疫组织化学分析结果(IL-2免疫组织化学染色,×200)。A示注射后1周,注射部位肌肉组织中炎性细胞浸润且IL-2表达(﹢);B示注射后2周,注射部位肌肉组织中炎性细胞浸润明显减少且IL-2表达(﹢﹣);C示注射后4周,注射部位肌肉组织中炎性细胞浸润消失,IL-2表达(﹣);PRP为富血小板血浆;IL-2为白细胞介素-2
[1]
Giusti I, D′Ascenzo S, Mancò A, et al. Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro[J]. Biomed Res Int, 2014, 2014:630870.
[2]
Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis[J]. Nat Rev Rheumatol, 2013, 9(12):721-730.
[3]
冯光,郝岱峰,褚万立,等. 自体单采富血小板血浆凝胶临床制作与应用[J/CD]. 中华损伤与修复杂志(电子版), 2016, 11(5):334-339.
[4]
Papait A, Cancedda R, Mastrogiacomo M, et al. Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J]. J Tissue Eng Regen Med, 2018, 12(1):30-43.
[5]
Andia I, Maffulli N. Platelet-rich Plasma for Muscle Injury and Tendinopathy[J]. Sports Med Arthrosc Rev, 2013, 21(4):191-198.
[6]
Li H, Li B. PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP[J]. J Vis Exp, 2013(74).
[7]
褚万立,郝岱峰,赵景峰,等. 富血小板血浆治疗深部胸骨切口感染一例并文献回顾[J/CD]. 中华损伤与修复杂志(电子版), 2017, 12(1):46-51.
[8]
Picard F, Hersant B, Bosc R, et al. The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care[J]. Wound Repair Regen, 2015, 23(5):638-643.
[9]
Greppi N, Mazzucco L, Galetti G, et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients[J]. Biologicals, 2011, 39(2):73-80.
[10]
Kon E, Filardo G, Delcogliano M, et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model[J]. BMC Musculoskelet Disord, 2010, 11:220.
[11]
Zhang ZY, Huang AW, Fan JJ, et al. The Potential Use of Allogeneic Platelet Rich Plasma for Large Bone Defect Treatment Immunogen city and Defect Healing Efficacy[J]. Cell Transplant, 2013, 22(1):175-187.
[12]
刘景汉,欧阳锡林,庄远,等. -80 ℃长期保存血小板的可行性研究[J]. 中国输血杂志,2008, 21(4):243-245.
[13]
Anitua E, Prado R, Orive G. Allogeneic Platelet-Rich Plasma: At the Dawn of an Off-the-Shelf Therapy[J]. Trends Biotechnol, 2017, 35(2):91-93.
[14]
Papait A, Cancedda R, Mastrogiacomo M, et al. Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J]. J Tissue Eng Regen Med, 2018, 12(1):30-43.
[15]
Sonker A, Dubey A, Bhatnagar A, et al. Platelet growth factors from allogeneic platelet-rich plasma for clinical improvement in split-thickness skin graft[J]. Asian J Transfus Sci, 2015, 9(2):155-158.
[16]
Jo CH, Shin JS, Lee SY, et al. ALLOGENEIC PLATELET-RICH PLASMA FOR ROTATOR CUFF REPAIR[J]. Acta Ortop Bras, 2017, 25(1):38-43.
[17]
Zhang ZY, Huang AW, Fan JJ, et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J]. Cell Transplant, 2013, 22(1):175-187.
[18]
Santoso S. Human platelet alloantigens[J]. Transfus Apher Sci, 2003, 28(3):227-236.
[19]
Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation[J]. Transpl Immunol, 2002, 10(2/3):165-181.
[20]
Harris PE, Cortesini R, Suciu-Foca N. Indirect allorecognition in solid organ transplantation[J]. Rev Immunogenet, 1999, 1(3):297-308.
[21]
Marino J, Paster J, Benichou G. Allorecognition by T Lymphocytes and Allograft Rejection[J]. Front Immunol, 2016, 7:582.
[22]
Pieri F, Lucarelli E, Corinaldesi G, et al. Effect of Mesenchymal Stem Cells and Platelet-Rich Plasma on the Healing of Standardized Bone Defects in the Alveolar Ridge: A Comparative Histomorphometric Study in Minipigs[J]. J Oral Maxillofac Surg, 2009, 67(2):265-272.
[1] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[2] 欧阳剑锋, 李炳权, 叶永恒, 胡少宇, 向阳. 关节镜联合富血小板血浆治疗粘连性肩周炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 765-772.
[3] 夏传龙, 迟健, 丛强, 连杰, 崔峻, 陈彦玲. 富血小板血浆联合关节镜治疗半月板损伤的临床疗效[J]. 中华关节外科杂志(电子版), 2023, 17(06): 877-881.
[4] 王泽勇, 覃健. 白细胞含量对富血小板血浆治疗运动系统损伤的影响[J]. 中华关节外科杂志(电子版), 2023, 17(05): 684-688.
[5] 张中斌, 付琨朋, 朱凯, 张玉, 李华. 胫骨高位截骨术与富血小板血浆治疗膝骨关节炎的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(05): 633-641.
[6] 詹钦文, 靳科, 袁家钦. 不同浓度自体富血小板血浆对慢性跟腱损伤的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(04): 500-507.
[7] 邬春虎, 马玉海, 陈长松, 尹华东, 朱晓峰, 何剑星, 刘彧. 冲击波联合富血小板血浆对骨关节炎软骨损伤的疗效[J]. 中华关节外科杂志(电子版), 2023, 17(03): 334-339.
[8] 贾星海, 张超, 林岩. 富血小板血浆对膝软骨损伤术后功能康复的影响[J]. 中华关节外科杂志(电子版), 2023, 17(01): 141-146.
[9] 韩李念, 王君. 放射性皮肤损伤治疗的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 533-537.
[10] 沈纵, 魏晨如, 朱邦晖, 包郁露, 伍国胜, 孙瑜. 间充质干细胞治疗吸入性损伤的动物实验研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 180-183.
[11] 祁焕康, 包俊杰, 张婧, 田琰, 卓么加, 祁万乐. 富血小板血浆联合微粒皮移植在高原地区老年慢性小创面中的临床研究[J]. 中华损伤与修复杂志(电子版), 2023, 18(01): 32-38.
[12] 胡国政, 刘飞, 徐丛, 吕剑, 王巍. 肩袖修补术联合足印区注射富血小板血浆的疗效分析[J]. 中华肩肘外科电子杂志, 2023, 11(02): 111-116.
[13] 马聪, 李雪靖, 郑晓佐, 张晓阳, 段坤峰, 刘国强, 郄素会. 关节腔内注射富血小板血浆与透明质酸钠治疗Ⅰ-Ⅲ期膝骨关节炎的对比研究[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 282-288.
[14] 苗壮, 刘培来. 富血小板血浆治疗膝骨关节炎的现状与展望[J]. 中华临床医师杂志(电子版), 2023, 17(01): 1-6.
[15] 赵晨怡, 宁波, 董浩, 冯秀雪, 李惠凯, 柴宁莉, 令狐恩强. 便携式一次性大孔道胃镜与常规胃镜在止血和内镜黏膜下剥离术中的应用对比:一项随机对照动物实验[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 14-19.
阅读次数
全文


摘要